AstraZeneca PLC
AZN
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kā¦ read more
Healthcare
Drug ManufacturersāGeneral
32 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$80.81
Price-0.51%
-$0.41
1Y
Price
Market Cap
$250.500b
Large
Price/Earnings 3y Avg5y Avg
30.4x
Premium
Premium
Financials Overview
Key metrics over the past few years+34.3%
EBITDA Margin+17.0%
Net Profit Margin+10.1%
Free Cash Flow MarginRevenue
$56.501b
+4.5%
1y CAGR+8.6%
3y CAGR+11.1%
5y CAGREarnings
$8.295b
+17.9%
1y CAGR+39.1%
3y CAGR+738.2%
5y CAGREPS
$2.67
+18.7%
1y CAGR+38.9%
3y CAGR+666.7%
5y CAGRBook Value
$44.810b
$112.422b
Assets$67.612b
Liabilities$32.839b
DebtDebt to Assets
29.2%
1.8x
Debt to EBITDAFree Cash Flow
$8.724b
+19.9%
1y CAGR+7.2%
3y CAGR+28.4%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company